Valuation: SPINEWAY

Market Cap 2.49M 2.84M 2.3M 2.12M 4.02M 272M 4.11M 27.62M 10.73M 133M 10.66M 10.42M 462M P/E 2026 *
-1.79x
P/E 2027 * -1.79x
Enterprise Value 8.99M 10.25M 8.3M 7.67M 14.54M 981M 14.83M 99.77M 38.76M 480M 38.49M 37.64M 1.67B EV / Sales 2026 *
0.68x
EV / Sales 2027 * 0.96x
Free-Float
9.65%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer 65 28/09/2005
Director of Finance/CFO - 01/11/2024
Director TitleAgeSince
Chairman 65 28/09/2005
Director/Board Member 48 13/10/2017
Director/Board Member 46 26/04/2016
Change 5-day change 1-year change 3-year change Capi.($)
-0.69%+3.25%-28.63%-10.50% 167B
-2.17%+3.55%-7.42%-4.52% 107B
+1.67%+7.33%+3.87%+62.20% 59.24B
+2.72%-4.06%+42.53%+53.20% 52.99B
-3.67%-1.53%-13.78%-41.40% 43.07B
-6.30%-3.43% - - 36.37B
+0.67%+7.55%-11.58%-41.55% 28.39B
-0.67%-3.10%+60.41%-4.82% 25.16B
-2.26%+0.56%-10.22%+3.68% 21.17B
Average -1.18%+1.56%+4.40%+2.04% 60.07B
Weighted average by Cap. -1.00%+2.01%-5.38%+2.50%

Financials

2026 *2027 *
Net sales 13.2M 15.05M 12.19M 11.26M 21.34M 1.44B 21.77M 147M 56.92M 705M 56.52M 55.28M 2.45B 14.5M 16.53M 13.39M 12.37M 23.45M 1.58B 23.92M 161M 62.53M 775M 62.08M 60.72M 2.69B
Net income -2.5M -2.85M -2.31M -2.13M -4.04M -273M -4.12M -27.75M -10.78M -134M -10.7M -10.47M -464M -2.5M -2.85M -2.31M -2.13M -4.04M -273M -4.12M -27.75M -10.78M -134M -10.7M -10.47M -464M
Net Debt 6.5M 7.41M 6M 5.55M 10.51M 710M 10.72M 72.14M 28.03M 347M 27.83M 27.22M 1.21B 11.4M 13M 10.52M 9.73M 18.43M 1.24B 18.8M 127M 49.16M 609M 48.81M 47.74M 2.11B
Logo SPINEWAY
Spineway designs, produces, and sells spinal column implants and surgical instruments. The group offers spinal systems, cervical and lumbar cages, cervical plates, bone substitutes, etc. Net sales are distributed geographically as follows: France (24.4%), Europe (16.9%), Latin America (34.3%), Asia (18.2%) and the Middle East and Africa (6.2%).
Employees
-